WEINSTEIN ROBERT 4
4 · PharmaCyte Biotech, Inc. · Filed Nov 22, 2023
Insider Transaction Report
Form 4
WEINSTEIN ROBERT
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-11-20+61,248→ 61,248 totalExercise: $2.18From: 2023-11-20Exp: 2033-11-20→ Common Stock (61,248 underlying)